Type 2 & other diabetes

A Couple-Based Intervention for Chinese Older Adults With Type 2 Diabetes: A Randomized Clinical Trial

JAMA Netw OpenPublished Randomised controlled trial

Primary result · Patients' HbA1cResult — go to the resultβ −0.08 95% CI −0.57 to 0.42

Authors' conclusion

These findings show that the overall treatment effect of the couple-based intervention was weak. However, the couple-based intervention benefited patients with poor glucose control. Patients' glucose levels, spouses' availability to provide support, and couples' collaborative preferences for mutual or individual diabetes management should be considered in tailoring treatment strategies among older adults with type 2 diabetes.

Study context

Population
Chinese patients aged ≥55 years with confirmed T2D and their spouses/cohabiting partners, 14 community health care centers in Guangzhou, China; prior T2D education and couples both with diabetes excluded
Participants
207 couples
Comparison
Couple-based intervention vs individual-based control
  • Couple-based interventionn = 106
  • Individual-based controln = 101reference
Primary endpoint
HbA1c for patients and quality of life for spouses
Follow-up
12-month follow-up
Methodological detailsmulticenter
  • Multicenter

Primary result

Patients' HbA1c

β

−0.08

95% CI −0.57 to 0.42

As reported in the abstract

Secondary outcomes

Collective efficacy and collective behavior

Increased in patients after intervention, similar magnitude between arms; no between-arm differences among spouses

Hemoglobin A1c (HbA1c), subgroup with baseline HbA1c ≥8.0%

Decreases in HbA1c constant and lasting, statistically significant difference

Original publication

A Couple-Based Intervention for Chinese Older Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. Published 2 January 2025. doi:10.1001/jamanetworkopen.2024.52168

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.